{
  "response": {
    "text": "Based on the search results, the paper that best describes the efficacy of MABp1 monotherapy compared to placebo when used to treat Colorectal cancer is titled \"MABp1 as a novel antibody treatment for advanced colorectal cancer: a randomised, double-blind, placebo-controlled, phase 3 study\". According to the study found in PubMed, the second author is:\n\nSA<Oncology Department, Saint Antoine Hospital, and Pierre and Marie Curie University (Paris 6), Paris, France>\n",
    "citations": [
      "https://tlcr.amegroups.org/article/view/71591/html"
    ]
  }
}